Literature DB >> 24815338

Normative data for the Rappel libre/Rappel indicé à 16 items (16-item Free and Cued Recall) in the elderly Quebec-French population.

Mélissa Dion1, Olivier Potvin, Sylvie Belleville, Guylaine Ferland, Mélanie Renaud, Louis Bherer, Sven Joubert, Guillaume T Vallet, Martine Simard, Isabelle Rouleau, Sarah Lecomte, Joël Macoir, Carol Hudon.   

Abstract

Performance on verbal memory tests is generally associated with socio-demographic variables such as age, sex, and education level. Performance also varies between different cultural groups. The present study aimed to establish normative data for the Rappel libre/Rappel indicé à 16 items (16-item Free and Cued Recall; RL/RI-16), a French adaptation of the Free and Cued Selective Reminding Test (Buschke, 1984; Grober, Buschke, Crystal, Bang, & Dresner, 1988). The sample consisted of 566 healthy French-speaking older adults (50-88 years old) from the province of Quebec, Canada. Normative data for the RL/RI-16 were derived from 80% of the total sample (normative sample) and cross-validated using the remaining participants (20%; validation sample). The effects of participants' age, sex, and education level were assessed on different indices of memory performance. Results indicated that these variables were independently associated with performance. Normative data are presented as regression equations with standard deviations (symmetric distributions) and percentiles (asymmetric distributions).

Entities:  

Keywords:  Episodic memory; French Canadian; Neuropsychological tests; Normative data; Older adults; Percentiles; Quebec.; Regressions; Word-list learning

Mesh:

Year:  2014        PMID: 24815338     DOI: 10.1080/13854046.2014.915058

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  7 in total

1.  Comparison of Standardization Methods for the Harmonization of Phenotype Data: An Application to Cognitive Measures.

Authors:  Lauren E Griffith; Edwin van den Heuvel; Parminder Raina; Isabel Fortier; Nazmul Sohel; Scott M Hofer; Hélène Payette; Christina Wolfson; Sylvie Belleville; Meghan Kenny; Dany Doiron
Journal:  Am J Epidemiol       Date:  2016-11-15       Impact factor: 4.897

2.  The Association Between Dietary Pattern Adherence, Cognitive Stimulating Lifestyle, and Cognitive Function Among Older Adults From the Quebec Longitudinal Study on Nutrition and Successful Aging.

Authors:  Matthew D Parrott; Pierre-Hugues Carmichael; Danielle Laurin; Carol E Greenwood; Nicole D Anderson; Guylaine Ferland; Pierrette Gaudreau; Sylvie Belleville; José A Morais; Marie-Jeanne Kergoat; Alexandra J Fiocco
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-02-17       Impact factor: 4.077

3.  Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study.

Authors:  Abdelkrim Ziad; Claudine Berr; Fabrice Ruiz; Bernard Bégaud; Cédric Lemogne; Marcel Goldberg; Marie Zins; Thibault Mura
Journal:  Drug Saf       Date:  2021-02-11       Impact factor: 5.606

4.  Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort.

Authors:  Abdelkrim Ziad; Romain Olekhnovitch; Fabrice Ruiz; Claudine Berr; Bernard Bégaud; Marcel Goldberg; Marie Zins; Thibault Mura
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-09-08       Impact factor: 10.154

5.  Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.

Authors:  Ariane Giguère-Rancourt; Marika Plourde; Eva Racine; Marianne Couture; Mélanie Langlois; Nicolas Dupré; Martine Simard
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

6.  Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.

Authors:  Simon Cloutier; Howard Chertkow; Marie-Jeanne Kergoat; Serge Gauthier; Sylvie Belleville
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.

Authors:  Mélanie Fortier; Christian-Alexandre Castellano; Valérie St-Pierre; Étienne Myette-Côté; Francis Langlois; Maggie Roy; Marie-Christine Morin; Christian Bocti; Tamas Fulop; Jean-Philippe Godin; Carla Delannoy; Bernard Cuenoud; Stephen C Cunnane
Journal:  Alzheimers Dement       Date:  2020-10-26       Impact factor: 21.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.